Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Clinical trial NCT02271711 · COMPLETED

Trial details

NCT number: NCT02271711
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Childhood Medulloblastoma Recurrent Ependymoma Recurrent Medulloblastoma

Start date: 2015-03-17
Primary completion: 2020-08-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.